SNDK heads into its Q3 2026 earnings report with a stock that has left most analyst targets in the dust — and the Street still scrambling to catch up.
The price action tells the story first. SNDK has gained 73% in a single month and 9% in the past week, closing at $1,064.21. That run has outpaced almost every analyst's pencil. Bank of America, which raised its target to $1,080 just two weeks ago, is barely above the current price. Wedbush lifted its target all the way to $1,200 yesterday — still only a 13% premium to where the stock already trades. The consensus mean target is $968, roughly 9% below the last close. In other words, the Street's implied upside has turned slightly negative, even after a wave of upgrades. The analyst recommendation factor ranks in the 98th percentile of the universe, reflecting how uniformly bullish the coverage has become — but at this price, bulls are essentially arguing the stock deserves a richer multiple rather than a higher absolute target.
The debate centres on whether SNDK's margin story can sustain the re-rating. Bulls point to a vertically integrated NAND business that has tilted aggressively toward higher-margin, high-capacity data-centre products, lifting average selling prices and gross margins. EPS momentum ranks in the 100th percentile on a 90-day basis — estimates have been rising consistently and sharply. Bears counter that the company remains tightly dependent on a narrow supplier base, carries meaningful IP litigation risk, and operates in a market where NAND pricing cycles can reverse quickly. The EV/EBITDA multiple has contracted roughly 4 points over the past month even as the stock rose, a sign the earnings revisions have run faster than the price — but that same dynamic leaves the stock with a PE of just ~14x, low for a name with this growth profile.
Short positioning is not a meaningful part of this story. Short interest is 6.4% of the free float — notable but not extreme — and borrow conditions remain relaxed, with cost to borrow under 0.45% and availability well within normal range. Short interest did jump roughly 15% over the past week, a step-up worth watching, but days to cover is just 0.26, suggesting no meaningful squeeze pressure is building. The ORTEX short score of 37 is moderate.
Options positioning has edged cautiously higher into the print. The put/call ratio has climbed to 1.10, about 1.4 standard deviations above its 20-day average of 1.01 — not extreme, but the highest reading in nearly a year. Insiders have been consistent sellers: the CEO, CFO, CTO and General Counsel all sold in February and April at prices ranging from $632 to $913. Those sales look increasingly well-timed, though they carry no signal about the fundamental outlook at current levels. Vanguard and Fidelity remain the dominant holders, with Vanguard adding over 1.6 million shares as of March 31.
The print is less a test of whether SNDK is growing and more a test of whether the margin and pricing trajectory can justify a stock that has already priced in a great deal of good news.
See the live data behind this article on ORTEX.
Open SNDK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
